Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer
In: Journal of radiation research, Jg. 61 (2019-07-23), Heft 2
Online
unknown
Zugriff:
Combining external beam radiotherapy (EBRT) with intracavitary brachytherapy (ICBT) is important for definitive treatment of cervical cancer. In cervical cancer patients receiving radiotherapy, we evaluated treatment outcomes in relation to dose–volume histogram parameters, including the computed tomography (CT)-based high-risk clinical target volume (HR-CTV) for ICBT. Between 2010 and 2015, 89 consecutive cervical cancer patients were mostly treated with 40 Gy of EBRT in 20 fractions and 18 Gy of ICBT prescribed to point A in 3 fractions. CT scans were obtained during ICBT. The HR-CTV D90 was calculated and the total doses of ICBT and EBRT were converted to the equivalent dose in 2 Gy fractions (EQD2). When the patients were divided into four groups according to EQD2 of the HR-CTV D90, the 3-year local recurrence-free survival rates were 95.2, 78.4, 52.7 and 42.9% for patients receiving >80 , 70–80 , 60–70 and 70 Gy is required for the better local control, especially in patients with a larger HR-CTV (≥22 cc at initial ICBT).
Titel: |
Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer
|
---|---|
Autor/in / Beteiligte Person: | Hori, Masakazu ; Fukushima, Yuuki ; Takada, Yu ; Gocho, Toshio ; Miura, Katsutoshi ; Nakata, Kensei ; Someya, Masanori ; Hasegawa, Tomokazu ; Sakata, Koh-ichi ; Kitagawa, Mio ; Tsuchiya, Takaaki |
Link: | |
Zeitschrift: | Journal of radiation research, Jg. 61 (2019-07-23), Heft 2 |
Veröffentlichung: | 2019 |
Medientyp: | unknown |
ISSN: | 1349-9157 (print) |
Schlagwort: |
|
Sonstiges: |
|